Ultragenyx Pharmaceu (RARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Sales | 0 | 0 | 0 | 0 | 986,914 |
| Cost of Goods | N/A | N/A | N/A | N/A | 361,949 |
| Gross Profit | N/A | N/A | N/A | N/A | 624,965 |
| Operating Expenses | 56,778 | 32,280 | 15,985 | 6,561 | 549,246 |
| Operating Income | -56,778 | -32,280 | -15,985 | -6,561 | 76,668 |
| Interest Expense | 0 | 0 | 0 | 270 | 2,620 |
| Other Income | -3,024 | -2,790 | -349 | -18 | -109 |
| Pre-tax Income | -59,802 | -35,070 | -16,334 | -6,849 | 73,939 |
| Income Tax | N/A | N/A | N/A | N/A | 23,943 |
| Net Income Continuous | -59,802 | -35,070 | -16,334 | -6,849 | 49,996 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | -10,625 |
| Net Income | $-59,802 | $-35,070 | $-16,334 | $-6,849 | $39,371 |
| EPS Basic Total Ops | -2.25 | -14.87 | -14.20 | -4.62 | N/A |
| EPS Basic Continuous Ops | -2.08 | -10.37 | -11.86 | -4.24 | N/A |
| EPS Diluted Total Ops | -2.25 | -14.87 | -14.20 | -4.62 | N/A |
| EPS Diluted Continuous Ops | -2.08 | -10.37 | -11.86 | -4.24 | N/A |
| EBITDA(a) | $-52,494 | $-30,423 | $-15,672 | $-6,527 | $76,668 |